ID

19000

Descripción

Safety and Effectiveness Study of Docetaxel and ZD1839 Followed by Removal of the Prostate to Treat Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00242918

Link

https://clinicaltrials.gov/show/NCT00242918

Palabras clave

Versiones (1)
  1. 29/11/16 29/11/16 -
Subido en

29 de noviembre de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Prostate Cancer NCT00242918

Inglés

Eligibility Prostate Cancer NCT00242918

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
prostate carcinoma: clinical stage t2b-3 or serum psa>20 ng/ml or gleason sum score 8-10.
Descripción

Prostate carcinoma TNM clinical staging | Prostate specific antigen measurement | Gleason score

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0600139
UMLS CUI [1,2]
C3258246
UMLS CUI [2]
C0201544
UMLS CUI [3]
C3203027
clinical t2 patients are eligible if endorectal coil mri shows t3 disease, or gleason 4+3 cancer in 5 or more biopsies (minimum of 10 biopsies total required)
Descripción

TNM clinical staging | Magnetic Resonance Imaging Coils, Endorectal | Gleason score | Biopsy Quantity

Tipo de datos

boolean

Alias
UMLS CUI [1]
C3258246
UMLS CUI [2]
C3857139
UMLS CUI [3]
C3203027
UMLS CUI [4,1]
C0005558
UMLS CUI [4,2]
C1265611
ecog performance status of 0, 1 or 2
Descripción

ECOG performance status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1520224
adequate hematological, liver and renal function
Descripción

Hematologic function Liver function Renal function

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0221130
UMLS CUI [1,2]
C0232741
UMLS CUI [1,3]
C0232804
existing peripheral neuropathy < grade 1
Descripción

Peripheral Neuropathy CTCAE Grades

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0031117
UMLS CUI [1,2]
C1516728
ability to tolerate oral medications.
Descripción

oral medication Receive Ability

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0175795
UMLS CUI [1,2]
C1514756
UMLS CUI [1,3]
C0085732
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
concurrent or prior treatment with radiation, cytotoxic, biologic therapy for prostate cancer
Descripción

Therapeutic radiology procedure Prostate carcinoma | Cytotoxic therapy Prostate carcinoma | Biological treatment Prostate carcinoma

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1522449
UMLS CUI [1,2]
C0600139
UMLS CUI [2,1]
C0677881
UMLS CUI [2,2]
C0600139
UMLS CUI [3,1]
C1531518
UMLS CUI [3,2]
C0600139
any major surgery within four weeks
Descripción

major surgery

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0679637
prior hormonal therapy (except finasteride for obstructive voiding symptoms--evidence of metastatic disease, confirmed by physical examination, computed tomography of the abdomen and pelvis within 45 days and by bone scan within 60 days of signing informed consent
Descripción

Hormone Therapy | Finasteride | Voiding Disorder Obstructive | Neoplasm Metastasis | Physical Examination | CT of abdomen | Computed Tomography (CT) of Pelvis | Scan of bone | Informed Consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0279025
UMLS CUI [2]
C0060389
UMLS CUI [3,1]
C4053857
UMLS CUI [3,2]
C0549186
UMLS CUI [4]
C0027627
UMLS CUI [5]
C0031809
UMLS CUI [6]
C0412620
UMLS CUI [7]
C0412628
UMLS CUI [8]
C0203668
UMLS CUI [9]
C0021430
Volver a la parte superior de la página

Similar models

Eligibility Prostate Cancer NCT00242918

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Prostate carcinoma TNM clinical staging | Prostate specific antigen measurement | Gleason score
Item
prostate carcinoma: clinical stage t2b-3 or serum psa>20 ng/ml or gleason sum score 8-10.
boolean
C0600139 (UMLS CUI [1,1])
C3258246 (UMLS CUI [1,2])
C0201544 (UMLS CUI [2])
C3203027 (UMLS CUI [3])
TNM clinical staging | Magnetic Resonance Imaging Coils, Endorectal | Gleason score | Biopsy Quantity
Item
clinical t2 patients are eligible if endorectal coil mri shows t3 disease, or gleason 4+3 cancer in 5 or more biopsies (minimum of 10 biopsies total required)
boolean
C3258246 (UMLS CUI [1])
C3857139 (UMLS CUI [2])
C3203027 (UMLS CUI [3])
C0005558 (UMLS CUI [4,1])
C1265611 (UMLS CUI [4,2])
ECOG performance status
Item
ecog performance status of 0, 1 or 2
boolean
C1520224 (UMLS CUI [1])
Hematologic function Liver function Renal function
Item
adequate hematological, liver and renal function
boolean
C0221130 (UMLS CUI [1,1])
C0232741 (UMLS CUI [1,2])
C0232804 (UMLS CUI [1,3])
Peripheral Neuropathy CTCAE Grades
Item
existing peripheral neuropathy < grade 1
boolean
C0031117 (UMLS CUI [1,1])
C1516728 (UMLS CUI [1,2])
oral medication Receive Ability
Item
ability to tolerate oral medications.
boolean
C0175795 (UMLS CUI [1,1])
C1514756 (UMLS CUI [1,2])
C0085732 (UMLS CUI [1,3])
Item Group
C0680251 (UMLS CUI)
Therapeutic radiology procedure Prostate carcinoma | Cytotoxic therapy Prostate carcinoma | Biological treatment Prostate carcinoma
Item
concurrent or prior treatment with radiation, cytotoxic, biologic therapy for prostate cancer
boolean
C1522449 (UMLS CUI [1,1])
C0600139 (UMLS CUI [1,2])
C0677881 (UMLS CUI [2,1])
C0600139 (UMLS CUI [2,2])
C1531518 (UMLS CUI [3,1])
C0600139 (UMLS CUI [3,2])
major surgery
Item
any major surgery within four weeks
boolean
C0679637 (UMLS CUI [1])
Hormone Therapy | Finasteride | Voiding Disorder Obstructive | Neoplasm Metastasis | Physical Examination | CT of abdomen | Computed Tomography (CT) of Pelvis | Scan of bone | Informed Consent
Item
prior hormonal therapy (except finasteride for obstructive voiding symptoms--evidence of metastatic disease, confirmed by physical examination, computed tomography of the abdomen and pelvis within 45 days and by bone scan within 60 days of signing informed consent
boolean
C0279025 (UMLS CUI [1])
C0060389 (UMLS CUI [2])
C4053857 (UMLS CUI [3,1])
C0549186 (UMLS CUI [3,2])
C0027627 (UMLS CUI [4])
C0031809 (UMLS CUI [5])
C0412620 (UMLS CUI [6])
C0412628 (UMLS CUI [7])
C0203668 (UMLS CUI [8])
C0021430 (UMLS CUI [9])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial